Economic evaluation of bivalirudin with provisional glycoprotein IIB/IIIA inhibition versus heparin with routine glycoprotein IIB/IIIA inhibition for percutaneous coronary intervention: results from the REPLACE-2 trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15519009

J. Am. Coll. Cardiol. 2004 Nov 2 44 9 1792-800

Download in:

View as

Triples

General Info

PMID
15519009